AdvisorShares Psychedelics ETF (PSIL)
NYSEARCA: PSIL · Real-Time Price · USD
16.77
-0.07 (-0.42%)
Aug 5, 2025, 4:00 PM - Market closed
PSIL Holdings Information
PSIL is an equity ETF with a total of 26 individual holdings. The top holdings are Atai Life Sciences stock at 13.51%, Mind Medicine (MindMed) at 7.69%, Quantum BioPharma at 7.29%, COMPASS Pathways at 6.95%, and Cybin at 6.68%.
Total Holdings
26
Top 10 Percentage
70.81%
Asset Class
Equity
ETF Category
Miscellaneous Sector
Assets
13.16M
PE Ratio
n/a
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | ATAI | Atai Life Sciences N.V. | 13.51% |
| 2 | MNMD | Mind Medicine (MindMed) Inc. | 7.69% |
| 3 | CSE: QNTM | Quantum BioPharma Ltd. | 7.29% |
| 4 | CMPS | COMPASS Pathways plc | 6.95% |
| 5 | NEO: CYBN | Cybin Inc. | 6.68% |
| 6 | n/a | Cash | 5.92% |
| 7 | STIM | Neuronetics, Inc. | 5.79% |
| 8 | ALKS | Alkermes plc | 5.75% |
| 9 | NRXP | NRx Pharmaceuticals, Inc. | 5.68% |
| 10 | GHRS | GH Research PLC | 5.54% |
| 11 | NBIX | Neurocrine Biosciences, Inc. | 5.00% |
| 12 | VTGN | Vistagen Therapeutics, Inc. | 4.93% |
| 13 | NEUP | Neuphoria Therapeutics Inc. | 4.48% |
| 14 | CSE: DRUG | Bright Minds Biosciences Inc. | 4.33% |
| 15 | RLMD | Relmada Therapeutics, Inc. | 1.95% |
| 16 | TTTXX | BlackRock Treasury Trust Fund | 1.64% |
| 17 | CMND | Clearmind Medicine Inc. | 1.50% |
| 18 | IXHL | Incannex Healthcare Inc. | 1.25% |
| 19 | KTTA | Pasithea Therapeutics Corp. | 1.24% |
| 20 | SILO | Silo Pharma, Inc. | 1.23% |
| 21 | ENVB | Enveric Biosciences, Inc. | 0.92% |
| 22 | TSX: NUMI | Numinus Wellness Inc. | 0.64% |
| 23 | PBM | Psyence Biomedical Ltd. | 0.09% |
| 24 | n/a | Sage Therapeutics Cvr | 0.00% |
| 25 | CSE: QNTM | Quantum BioPharma Ltd. | 0.00% |
As of Aug 1, 2025